The Guangzhou-based consortium will include KingMed Diagnostics, Daan Gene and others in a South China Precision Medical and Translational Medicine Center” which includes gene sequencing,in vitro diagnostics, molecular imaging, cancer treatment, a maternity hospital and an auxiliary reproductive center, and immune cell therapy applied research. The consortium will also help to develop modern TCM which is considered a genuine Chinese personalized medicine and might offer a much more rational approach in future through the use and management of “big data”. “
China Bio news release, July 7, 2017